Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Criteria for selective screening for Chlamydia trachomatis.

Maarit Paukku1, Riika Kilpikari, Mirja Puolakkainen

  • 1Department of Obstetrics and Gynecology and Haartman Institute, University of Helsinki, Finland. Maarit.Paukku@hus.fi

Sexually Transmitted Diseases
|February 5, 2003
PubMed
Summary

Screening all women aged 30 or younger for genital chlamydia infection is more effective than screening only those 25 or younger. Age remains a key factor in effective chlamydia prevention strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decreased chlamydia notifications in six European Union/European Economic Area countries and England, 2024.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Prior <i>Chlamydia trachomatis</i> Infection and the Risk of Epithelial Ovarian Cancer and Borderline Ovarian Tumors.

Anticancer research·2026
Same author

Human papillomavirus vaccinations' association to childbirth rates.

Human vaccines & immunotherapeutics·2026
Same author

Multicentre Trial Evaluating the Safety and Tolerability of Estetrol-Drospirenone Combined Oral Contraceptive in Postmenarchal Female Adolescents.

Journal of clinical medicine·2025
Same author

Induced abortion rates among women vaccinated against human papillomavirus: Registry-based follow-up of a community-randomized trial.

Preventive medicine·2025
Same author

Serum IgG1 and IgG3 Antibodies to Chlamydia trachomatis Pgp3 and Hsp60 in Men of Subfertile Couples.

The Journal of infectious diseases·2025

Area of Science:

  • Reproductive health
  • Infectious disease prevention
  • Public health screening

Background:

  • Current guidelines recommend screening all women aged 25 or younger for genital chlamydia based on diverse population studies.
  • Limited data exists for screening criteria in homogenous populations with low chlamydia prevalence.

Purpose of the Study:

  • To determine optimal screening criteria for genital chlamydia in a homogenous population.
  • To evaluate the effectiveness of age-based screening in a low-prevalence setting.

Main Methods:

  • A study involving 1198 women at family planning clinics.
  • Data collection through screening and risk factor surveys.
  • Multivariate logistic regression analysis to identify risk markers.

Related Experiment Videos

Main Results:

  • Overall chlamydia prevalence was 3.5%.
  • Key risk factors identified: marital status, number of sex partners, and age.
  • Screening women aged 25 or younger identified only 28% of infections.
  • Screening women aged 30 or younger identified 83% of infections.

Conclusions:

  • Age remains a feasible primary screening criterion for genital chlamydia.
  • Extending screening to include women up to age 30 significantly improves detection rates.
  • Consideration should be given to revising screening guidelines to include women up to 30 years of age.